These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24265131)

  • 1. Aqueous biphasic cancer cell migration assay enables robust, high-throughput screening of anti-cancer compounds.
    Lemmo S; Nasrollahi S; Tavana H
    Biotechnol J; 2014 Mar; 9(3):426-34. PubMed ID: 24265131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated tracking of unmarked cells migrating in three-dimensional matrices applied to anti-cancer drug screening.
    Adanja I; Debeir O; Mégalizzi V; Kiss R; Warzée N; Decaestecker C
    Exp Cell Res; 2010 Jan; 316(2):181-93. PubMed ID: 19835872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tapered microtract array platform for antimigratory drug screening of human glioblastoma multiforme.
    Cha J; Koh I; Choi Y; Lee J; Choi C; Kim P
    Adv Healthc Mater; 2015 Feb; 4(3):405-11. PubMed ID: 25230171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of fluorescence imaging based assay for screening compounds with anti-migration activity].
    Nie XJ; Zhao XP; Wang Y
    Yao Xue Xue Bao; 2011 Jul; 46(7):793-7. PubMed ID: 22010348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-Time Cell Migration Monitoring to Analyze Drug Synergism in the Scratch Assay Using the IncuCyte System.
    Kobelt D; Walther W; Stein US
    Methods Mol Biol; 2021; 2294():133-142. PubMed ID: 33742398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues.
    Drewitz M; Helbling M; Fried N; Bieri M; Moritz W; Lichtenberg J; Kelm JM
    Biotechnol J; 2011 Dec; 6(12):1488-96. PubMed ID: 22102438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytochemicals potently inhibit migration of metastatic breast cancer cells.
    Ham SL; Nasrollahi S; Shah KN; Soltisz A; Paruchuri S; Yun YH; Luker GD; Bishayee A; Tavana H
    Integr Biol (Camb); 2015 Jul; 7(7):792-800. PubMed ID: 26120051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a novel fiber optic fluorescence device for multiplexed high-throughput cytotoxic screening.
    Lee D; Barnes S
    J Exp Ther Oncol; 2010; 8(3):235-45. PubMed ID: 20734922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An automated high-content assay for tumor cell migration through 3-dimensional matrices.
    Echeverria V; Meyvantsson I; Skoien A; Worzella T; Lamers C; Hayes S
    J Biomol Screen; 2010 Oct; 15(9):1144-51. PubMed ID: 20930216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robotic production of cancer cell spheroids with an aqueous two-phase system for drug testing.
    Ham SL; Atefi E; Fyffe D; Tavana H
    J Vis Exp; 2015 Apr; (98):e52754. PubMed ID: 25939084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.
    Hirano T; Satow R; Kato A; Tamura M; Murayama Y; Saya H; Kojima H; Nagano T; Okabe T; Fukami K
    Biochem Pharmacol; 2013 Nov; 86(10):1419-29. PubMed ID: 24035834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An automatic and quantitative on-chip cell migration assay using self-assembled monolayers combined with real-time cellular impedance sensing.
    Wang L; Zhu J; Deng C; Xing WL; Cheng J
    Lab Chip; 2008 Jun; 8(6):872-8. PubMed ID: 18497905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric Analysis of Oncology Drug Screening with Aqueous Two-Phase Tumor Spheroids.
    Shahi Thakuri P; Ham SL; Luker GD; Tavana H
    Mol Pharm; 2016 Nov; 13(11):3724-3735. PubMed ID: 27653969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration.
    Decaestecker C; Debeir O; Van Ham P; Kiss R
    Med Res Rev; 2007 Mar; 27(2):149-76. PubMed ID: 16888756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative, facile, and high-throughput image-based cell migration method is a robust alternative to the scratch assay.
    Gough W; Hulkower KI; Lynch R; McGlynn P; Uhlik M; Yan L; Lee JA
    J Biomol Screen; 2011 Feb; 16(2):155-63. PubMed ID: 21297103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug effects analysis on cells using a high throughput microfluidic chip.
    Gong Z; Zhao H; Zhang T; Nie F; Pathak P; Cui K; Wang Z; Wong S; Que L
    Biomed Microdevices; 2011 Feb; 13(1):215-9. PubMed ID: 20978852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.